{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:56Z","timestamp":1791928916858,"version":"4.3.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00223-021-00837-0","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T21:59:06Z","timestamp":1616709546000},"page":"551-560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Bone Mineral Disease After Kidney Transplantation"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5160-3248","authenticated-orcid":false,"given":"Josep-Vicent","family":"Torregrosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1323-5293","authenticated-orcid":false,"given":"Ana Carina","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cucchiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3300-6033","authenticated-orcid":false,"given":"An\u00edbal","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"issue":"23","key":"837_CR1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","volume":"341","author":"RA Wolf","year":"1999","unstructured":"Wolf RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341(23):1725\u20131730","journal-title":"N Engl J Med"},{"key":"837_CR2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1681\/ASN.V132551","volume":"13","author":"A Torres","year":"2002","unstructured":"Torres A, Lorenzo V, Salido E (2002) Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 13:551\u2013558","journal-title":"J Am Soc Nephrol"},{"key":"837_CR3","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.01510506","volume":"1","author":"JR Weisinger","year":"2006","unstructured":"Weisinger JR, Carlini RG, Rojas E, Bellorin-Font E (2006) Bone disease after renal transplantation. Clin J Am Soc Nephrol 1:1300\u20131313","journal-title":"Clin J Am Soc Nephrol"},{"key":"837_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MNH.0b013e3283546ee0","volume":"21","author":"K Kalantar-Zadeh","year":"2012","unstructured":"Kalantar-Zadeh K, Molnar MZ, Kovesdy CP, Mucsi I, Bunnapradist S (2012) Management of mineral and bone disorder after kidney transplantation. Curr Opin Nephrol Hypertens 21:389\u2013403","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"837_CR5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nefro.2016.03.004","volume":"36","author":"A Torres","year":"2016","unstructured":"Torres A, Torregrosa JV, Marcen R et al (2016) Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study). Nefrologia 36:255\u2013267","journal-title":"Nefrologia"},{"key":"837_CR6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2215\/CJN.03920808","volume":"4","author":"P Evenepoel","year":"2009","unstructured":"Evenepoel P, Van der Bergh B, Naesens M, De Jonge H, Bammens B, Claes K et al (2009) Calcium metabolism in the early posttransplantation period. Clin J Am Soc Nephrol 4:665\u2013672","journal-title":"Clin J Am Soc Nephrol"},{"key":"837_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16457","author":"WY van der Plas","year":"2020","unstructured":"van der Plas WY, Gomes Neto AW, Berger SP et al (2020) Association of time-updated plasma calcium and phosphate with graft and patient outcomes after kidney transplantation. Am J Transplant. https:\/\/doi.org\/10.1111\/ajt.16457","journal-title":"Am J Transplant"},{"key":"837_CR8","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.transproceed.2009.06.073","volume":"41","author":"JV Torregrosa","year":"2009","unstructured":"Torregrosa JV, Bergua C, Mart\u00ednez de Osaba MJ, Oppenheimer F, Campistol JM (2009) Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on di\u00e1lisis. Transplant Proc 41:2396\u20132398","journal-title":"Transplant Proc"},{"key":"837_CR9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1399-0012.2011.01524.x","volume":"26","author":"P Evenepoel","year":"2012","unstructured":"Evenepoel P, Sprangers B, Lerut E et al (2012) Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study. Clin Transplant 26:393\u2013402","journal-title":"Clin Transplant"},{"key":"837_CR10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ndt\/13.suppl_3.94","volume":"13","author":"A Torres","year":"1998","unstructured":"Torres A, Rodr\u00edguez AP, Concepci\u00f3n MT, Garc\u00eda S, Rufino M, Mart\u00edn B et al (1998) Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations. Nephrol Dial Transplant 13:94\u201397","journal-title":"Nephrol Dial Transplant"},{"key":"837_CR11","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2215\/CJN.11371015","volume":"11","author":"A Bouquegneau","year":"2016","unstructured":"Bouquegneau A, Salam S, Delanaye P, Eastell R, Khwaja A (2016) Bone disease after kidney transplantation. Clin J Am Soc Nephrol 11:1282\u20131296","journal-title":"Clin J Am Soc Nephrol"},{"key":"837_CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2012.12.019","volume":"33","author":"P Evenepoel","year":"2013","unstructured":"Evenepoel P (2013) Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients. Semin Nephrol 33:191\u2013203","journal-title":"Semin Nephrol"},{"key":"837_CR13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.transproceed.2005.12.065","volume":"38","author":"FN Ozdemir","year":"2006","unstructured":"Ozdemir FN, Afsar B, Akgul A, Usluogullari C, Ak\u00e7ay A, Haberal M (2006) Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 38:480\u2013482","journal-title":"Transplant Proc"},{"key":"837_CR14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0012.2007.00690.x","volume":"21","author":"OI Egbuna","year":"2007","unstructured":"Egbuna OI, Taylor JG, Bushinsky DA (2007) Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant 21:558","journal-title":"Clin Transplant"},{"key":"837_CR15","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2005.00938.x","volume":"5","author":"W Gwinner","year":"2005","unstructured":"Gwinner W, Suppa S, Mengel M, Hoy L, Kreipe HH, Haller H et al (2005) Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant 5:1934\u20131941","journal-title":"Am J Transplant"},{"key":"837_CR16","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/j.1600-6143.2009.02792.x","volume":"9","author":"P Evenepoel","year":"2009","unstructured":"Evenepoel P, Lerut E, Naesens M et al (2009) Localization, etiology and impact of calcium phosphate deposits in renal allografts. Am J Transplant 9:2470\u20132478","journal-title":"Am J Transplant"},{"key":"837_CR17","first-page":"751","volume":"33","author":"JV Torregrosa","year":"2013","unstructured":"Torregrosa JV, Barros X (2013) Management of hypercalcemia after renal transplantation. Nefrologia 33:751\u2013757","journal-title":"Nefrologia"},{"key":"837_CR18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfh925","volume":"20","author":"AL Serra","year":"2005","unstructured":"Serra AL, Schwarz AA, Wick FH (2005) Succesful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparthyroidism. Nephrol Dial Transplant 20:1315\u20131317","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"837_CR19","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.transproceed.2007.07.079","volume":"39","author":"C Bergua","year":"2007","unstructured":"Bergua C, Torregrosa JV, Cof\u00e1n F, Oppenheimer F (2007) Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Transplant Proc 39(7):2254\u20132255","journal-title":"Transplant Proc"},{"key":"837_CR20","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/ndt\/gfm270","volume":"22","author":"AE Kruse","year":"2007","unstructured":"Kruse AE, Eisenberger U, Frey FL, Mohaupt MG (2007) Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 22:2362\u20132365","journal-title":"Nephrol Dial Transplant"},{"key":"837_CR21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfl583","volume":"22","author":"A Schwarz","year":"2007","unstructured":"Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H (2007) Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 22:584\u2013591","journal-title":"Nephrol Dial Transplant"},{"key":"837_CR22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/TP.0b013e3182530699","volume":"94","author":"RL Yang","year":"2012","unstructured":"Yang RL, Freeman K, Reinke CE et al (2012) Tertiary hyperparathyroidism in kidney transplant recipients: characteristics of patients selected for different treatment strategies. Transplantation 94:70\u201376","journal-title":"Transplantation"},{"key":"837_CR23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/SLA.0b013e3181728a2d","volume":"248","author":"F Triponez","year":"2008","unstructured":"Triponez F, Clark OH, Vanrenthergem Y, Evenepoel P (2008) Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg 248:18\u201330","journal-title":"Ann Surg"},{"key":"837_CR24","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2015060622","volume":"27","author":"JM Cruzado","year":"2016","unstructured":"Cruzado JM, Moreno P, Torregrosa JV et al (2016) A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J AM Soc Nephrol 27:2487\u20132494","journal-title":"J AM Soc Nephrol"},{"key":"837_CR25","first-page":"158","volume":"30","author":"JV Torregrosa","year":"2010","unstructured":"Torregrosa JV, Felez I, Fuser D (2010) Usefulness of imaging techniques in secondary hyperparathyroidism. Nefrologia 30:158\u2013167","journal-title":"Nefrologia"},{"key":"837_CR26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/nep.12801","volume":"22","author":"J Chen","year":"2017","unstructured":"Chen J, Jia X, Kong X et al (2017) Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: a systematic review and meta-analysis. Nephrology 22:388\u2013396","journal-title":"Nephrology"},{"key":"837_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijsu.2017.06.029","volume":"44","author":"M-E Liu","year":"2017","unstructured":"Liu M-E, Qiu N-C, Zha S-L et al (2017) To assess the effects of parathyroidectomy (TPTX versus TPTX+AT) for secondary hyperparathyroidism in chronic renal failure: a systematic review and meta-analysis. Int J Surg 44:353\u2013362","journal-title":"Int J Surg"},{"key":"837_CR28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/hdi.12639","volume":"22","author":"T F\u00fcl\u00f6p","year":"2018","unstructured":"F\u00fcl\u00f6p T, Koch CA, Farah Musa AR et al (2018) Targeted surgical parathyroidectomy in end-stage renal disease patients and long-term metabolic control: a single-center experience in the current era. Hemodial Int 22:394\u2013404","journal-title":"Hemodial Int"},{"key":"837_CR29","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1046\/j.1523-1755.2001.00755.x","volume":"59","author":"M Levi","year":"2001","unstructured":"Levi M (2001) Posttransplant hypophosphatemia. Kidney Int 59:2377\u20132387","journal-title":"Kidney Int"},{"key":"837_CR30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-3046.2010.01405.x","volume":"15","author":"W Seeherunvong","year":"2011","unstructured":"Seeherunvong W, Wolf M (2011) Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation. Pediatr Transplant 15:37\u201346","journal-title":"Pediatr Transplant"},{"key":"837_CR31","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/TP.0b013e318264fc08","volume":"94","author":"X Barros","year":"2012","unstructured":"Barros X, Torregrosa JV, Mart\u00ednez de Osaba MJ, Casals G, Paschoalin R, Dur\u00e1n CE et al (2012) EarlierdecreaseofFGF-23andless hypophosphatemiainpreemptivekidneytransplantrecipients. Transplantation 94:830\u2013836","journal-title":"Transplantation"},{"key":"837_CR32","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2215\/CJN.01310308","volume":"3","author":"P Evenepoel","year":"2008","unstructured":"Evenepoel P, Meijers BK, de Jonge H, Naesens M, Bammens B, Claes K et al (2008) Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol 3:1829\u20131836","journal-title":"Clin J Am Soc Nephrol"},{"issue":"32\u201340","key":"837_CR33","first-page":"9","volume":"6","author":"HH Malluche","year":"2010","unstructured":"Malluche HH, Monier-Faugere MC, Herberth J (2010) Bone disease after renal transplantation. Nat Rev Nephrol 6(32\u201340):9","journal-title":"Nat Rev Nephrol"},{"key":"837_CR34","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1440-1797.2010.01234.x","volume":"15","author":"S Chadban","year":"2010","unstructured":"Chadban S, Chan M, Fry R et al (2010) The CARI guideline Nutritional management of hypophosphatemia in adult kidney transplant recipients. Nephrology 15:S48-51","journal-title":"Nephrology"},{"key":"837_CR35","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1093\/ndt\/13.10.2605","volume":"13","author":"F Caravaca","year":"1998","unstructured":"Caravaca F, Fernandez MA, Ruiz-Calero R et al (1998) Effectos of oral phosphorus supplementation on mineral metabolism of renal transplant recipients. Nephrol Dial Transplant 13:2605\u20132611","journal-title":"Nephrol Dial Transplant"},{"key":"837_CR36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0272-6386(99)70045-4","volume":"34","author":"PM Amb\u00fchl","year":"1999","unstructured":"Amb\u00fchl PM, Meier D, Wolf B et al (1999) Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism and acid\/base homeostasis. Am J Kidney Dis 34:875\u2013883","journal-title":"Am J Kidney Dis"},{"key":"837_CR37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/j.ajkd.2010.11.024","volume":"57","author":"LV Riella","year":"2011","unstructured":"Riella LV, Rennke HG, Grafals M et al (2011) Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy. Am J Kidney Dis 57:641\u2013645","journal-title":"Am J Kidney Dis"},{"key":"837_CR38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5414\/CNP63087","volume":"63","author":"M Balal","year":"2005","unstructured":"Balal M, Paydas S, Seyrek N et al (2005) Dipyridamole for renal phosphate leak in successfully renal transplanted hypophosphatemic patients. Clin Nephrol 63:87\u201391","journal-title":"Clin Nephrol"},{"key":"837_CR39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","volume":"325","author":"BA Julian","year":"1991","unstructured":"Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544\u2013550","journal-title":"N Engl J Med"},{"key":"837_CR40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.kint.2016.10.008","volume":"91","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel P, Behets GJ, Viaene L, D\u2019Haese PC (2017) Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation. Kidney Int 91:469\u2013476","journal-title":"Kidney Int"},{"key":"837_CR41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1681\/ASN.2018060656","volume":"30","author":"IDB Marques","year":"2019","unstructured":"Marques IDB, Araujo M, Graciolli FG et al (2019) A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation. J Am Soc Nephrol 30:355\u2013365","journal-title":"J Am Soc Nephrol"},{"key":"837_CR42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2215\/CJN.09950818","volume":"14","author":"S Keronen","year":"2019","unstructured":"Keronen S, Martola L, Finne P, Burton IS, Kroger H, Honkanen E (2019) Changes in bone histomorphometry after kidney transplantation. Clin J Am Soc Nephrol 14:894\u2013903","journal-title":"Clin J Am Soc Nephrol"},{"key":"837_CR43","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1359\/jbmr.2001.16.10.1863","volume":"16","author":"S Patel","year":"2001","unstructured":"Patel S, Kwan JT, McCloskey E, McGee G, Thomas G, Johnson D et al (2001) Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 16:1863\u20131870","journal-title":"J Bone Miner Res"},{"issue":"1","key":"837_CR44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P et al (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336","journal-title":"Kidney Int"},{"issue":"suppl 1","key":"837_CR45","first-page":"3","volume":"31","author":"JV Torregrosa","year":"2011","unstructured":"Torregrosa JV, Bover J, Cannata-Andia J et al (2011) Spanish society of nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients. Nefrologia 31(suppl 1):3\u201332","journal-title":"Nefrologia"},{"key":"837_CR46","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/01.TP.0000131990.13277.28","volume":"77","author":"VM Brandenburg","year":"2004","unstructured":"Brandenburg VM, Politt D, Ketteler M, Fassbender WJ, Heussen N, Westenfeld R et al (2004) Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation. Transplantation 77:1566\u20131571","journal-title":"Transplantation"},{"key":"837_CR47","first-page":"2224","volume":"27","author":"JV Torregrosa","year":"1995","unstructured":"Torregrosa JV, Campistol JM, Montesinos M, Fenollosa B, Pons F, Mart\u00ednez de Osaba MJ et al (1995) Factorsinvolvedinthelossofbone mineral density after renal transplantation. Transplant Proc 27:2224\u20132225","journal-title":"Transplant Proc"},{"key":"837_CR48","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","volume":"145","author":"CA O\u2019Brien","year":"2004","unstructured":"O\u2019Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA et al (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835\u20131841","journal-title":"Endocrinology"},{"key":"837_CR49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007890-199702150-00009","volume":"63","author":"A Aroldi","year":"1997","unstructured":"Aroldi A, Tarantino A, Montagnino G, Cesana B, Cocucci C, Ponticelli C (1997) Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients. Transplantation 63:380\u2013386","journal-title":"Transplantation"},{"key":"837_CR50","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jcb.21411","volume":"103","author":"UK Singha","year":"2008","unstructured":"Singha UK, Jiang Y, Yu S, Luo M, Lu Y, Zhang J et al (2008) Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J Cell Biochem 103:434\u2013446","journal-title":"J Cell Biochem"},{"key":"837_CR51","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bone.2004.07.013","volume":"35","author":"M Kneissel","year":"2004","unstructured":"Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein- Mecker S, Kossida S et al (2004) Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. Bone 35:1144\u20131156","journal-title":"Bone"},{"key":"837_CR52","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1523-1755.1999.00589.x","volume":"56","author":"H Bonarek","year":"1999","unstructured":"Bonarek H, Merville P, Bonarek M et al (1999) Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 56:642\u2013649","journal-title":"Kidney Int"},{"key":"837_CR53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12020-014-0312-0","volume":"48","author":"JV Torregrosa","year":"2015","unstructured":"Torregrosa JV, Fuster D, Duran CE et al (2015) Set point of calcium in severe secondary hyperparathyroidism is altered and does not change after successful kidney transplantation. Endocrine 48:709\u2013711","journal-title":"Endocrine"},{"key":"837_CR54","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","volume":"19","author":"P Evenepoel","year":"2004","unstructured":"Evenepoel P, Claes K, Kuypers D et al (2004) Natural history of parathyroid function andcalcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 19:1281\u20131287","journal-title":"Nephrol Dial Transplant"},{"key":"837_CR55","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","volume":"13","author":"P Perrin","year":"2013","unstructured":"Perrin P, Caillard S, Javier RM et al (2013) Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation. Am J Transplant 13:2653\u20132663","journal-title":"Am J Transplant"},{"key":"837_CR56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000187765","volume":"66","author":"MK Almond","year":"1994","unstructured":"Almond MK, Kwan JTC, Evans K, Cunningham J (1994) Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66:52\u201357","journal-title":"Nephron"},{"key":"837_CR57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/ajkd.2000.8289","volume":"36","author":"RG Carlini","year":"2000","unstructured":"Carlini RG, Rojas E, Weisinger JR, Lopez M, Martinis R, Arminio A et al (2000) Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 36:160\u2013165","journal-title":"Am J Kidney Dis"},{"key":"837_CR58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00198-004-1653-y","volume":"16","author":"SD Roe","year":"2005","unstructured":"Roe SD, Porter CJ, Godber IM, Hosking DJ, Cassidy MJ (2005) Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism. Osteoporos Int 16:142\u2013148","journal-title":"Osteoporos Int"},{"key":"837_CR59","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jcem.83.11.5249","volume":"83","author":"M Abdelhadi","year":"1998","unstructured":"Abdelhadi M, Nordenstrom J (1998) Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab 83:3845\u20133851","journal-title":"J Clin Endocrinol Metab"},{"key":"837_CR60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/TP.0b013e31817c13e1","volume":"86","author":"C Bergua","year":"2008","unstructured":"Bergua C, Torregrosa JV, Fuster D, Gutierrez-Dalmau A, Oppenheimer F, Campistol JM (2008) Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation 86:413\u2013417","journal-title":"Transplantation"},{"key":"837_CR61","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1046\/j.1523-1755.2003.00938.x","volume":"63","author":"E Rojas","year":"2003","unstructured":"Rojas E, Carlini RG, Clesca P, Arminio A, Suniaga O, De Elguezabal K et al (2003) The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int 63:1915\u20131923","journal-title":"Kidney Int"},{"key":"837_CR62","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/TP.0b013e31828eead8","volume":"95","author":"KL Naylor","year":"2013","unstructured":"Naylor KL, Li AH, Lam NN, Hodsman AB, Jamal SA, Garg AX (2013) Fracture risk in kidney transplant recipients: a systematic review. Transplantation 95:1461\u20131470","journal-title":"Transplantation"},{"key":"837_CR63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jbm4.10067","volume":"3","author":"A Sidibe","year":"2019","unstructured":"Sidibe A, Auguste D, Desbiens LC et al (2019) Fracture risk in dialysis and kidney transplanted patients: a systematic review. JBMR Plus 3:45\u201355","journal-title":"JBMR Plus"},{"key":"837_CR64","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","volume":"95","author":"P Evenepoel","year":"2019","unstructured":"Evenepoel P, Claes K, Meijers B et al (2019) Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients. Kidney Int 95:1461\u20131470","journal-title":"Kidney Int"},{"issue":"12","key":"837_CR65","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1097\/TP.0b013e3181a6bbda","volume":"87","author":"LE Nikkel","year":"2009","unstructured":"Nikkel LE, Hollenbeak CS, Fox EJ, Uemura T, Ghahramani N (2009) Risk of fractures after renal transplantation in the United States. Transplantation 87(12):1846\u20131851","journal-title":"Transplantation"},{"issue":"12","key":"837_CR66","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1111\/j.1600-6143.2008.02423.x","volume":"8","author":"S Akaberi","year":"2008","unstructured":"Akaberi S, Simonsen O, Linderg\u00e5rd B, Nyberg G (2008) Can DXA predict fractures in renal transplant patients? Am J Transplant 8(12):2647\u20132651","journal-title":"Am J Transplant"},{"key":"837_CR67","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMcp1800214","volume":"379","author":"L Buckley","year":"2018","unstructured":"Buckley L, Humphrey MB (2018) Glucocorticoid-Induced Osteoporosis. N Engl J Med 379:2547\u20132556","journal-title":"N Engl J Med"},{"key":"837_CR68","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/01.ASN.0000016082.70875.36","volume":"13","author":"RG De S\u00e9vaux","year":"2002","unstructured":"De S\u00e9vaux RG, Hoitsma AJ, Corstens FH, Wetzels JF (2002) Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol 13:1608\u20131614","journal-title":"J Am Soc Nephrol"},{"key":"837_CR69","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1523-1755.2004.00432.x","volume":"65","author":"A Torres","year":"2004","unstructured":"Torres A, Garc\u00eda S, G\u00f3mez A, Gonz\u00e1lez A, Barrios Y, Concepci\u00f3n MT et al (2004) Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 65:705\u2013712","journal-title":"Kidney Int"},{"issue":"9","key":"837_CR70","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/TP.0b013e3181a23837","volume":"87","author":"R Marc\u00e9n","year":"2009","unstructured":"Marc\u00e9n R, del Castillo D, Capdevila L (2009) Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain. Transplantation 87(9):1340\u20131346","journal-title":"Transplantation"},{"issue":"6","key":"837_CR71","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000446863","volume":"43","author":"G Cianciolo","year":"2016","unstructured":"Cianciolo G, Galassi A, Capelli I et al (2016) Vitamin D in kidney transplant recipients: mechanisms and therapy. Am J Nephrol 43(6):397\u2013407","journal-title":"Am J Nephrol"},{"key":"837_CR72","doi-asserted-by":"crossref","first-page":"h3783","DOI":"10.1136\/bmj.h3783","volume":"351","author":"S Maraka","year":"2015","unstructured":"Maraka S, Kennel KA (2015) Bisphosphonates for the prevention and treatment of osteoporosis. BMJ 351:h3783","journal-title":"BMJ"},{"key":"837_CR73","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-015-3465-7","volume":"27","author":"J Wang","year":"2016","unstructured":"Wang J, Yao M, Xu JH et al (2016) Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials. Osteoporos Int 27:1683\u20131690","journal-title":"Osteoporos Int"},{"issue":"1","key":"837_CR74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00198-010-1197-2","volume":"22","author":"JV Torregrosa","year":"2011","unstructured":"Torregrosa JV, Fuster D, Monegal A, Gentil MA, Bravo J, Guirado L et al (2011) Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant. Osteoporos Int 22(1):281\u2013287","journal-title":"Osteoporos Int"},{"issue":"12","key":"837_CR75","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/TP.0b013e3181dc13d0","volume":"89","author":"JV Torregrosa","year":"2010","unstructured":"Torregrosa JV, Fuster D, Gentil MA, Marcen R, Guirado L, Zarraga S et al (2010) Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients. Transplantation 89(12):1476\u20131481","journal-title":"Transplantation"},{"key":"837_CR76","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Eng J Med 361:756\u2013756","journal-title":"N Eng J Med"},{"issue":"8","key":"837_CR77","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","volume":"26","author":"S Jamal","year":"2011","unstructured":"Jamal S, Ljunggren O, Stehman-Breen C, Cummings SR, McClung MR, Goemaere S et al (2011) Effects of denosumab on fractures and bone mineral density by level of kidney function. J Bone Miner Res 26(8):1829\u20131835","journal-title":"J Bone Miner Res"},{"key":"837_CR78","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","volume":"16","author":"M Bonani","year":"2016","unstructured":"Bonani M, Frey D, Brockmann J et al (2016) Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial. Am J Transplant 16:1882\u20131891","journal-title":"Am J Transplant"},{"key":"837_CR79","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1097\/TP.0000000000001547","volume":"101","author":"M Bonani","year":"2017","unstructured":"Bonani M, Frey D, de Rougemont O et al (2017) Infections in De novo kidney transplant recipients treated with the RANKL inhibitor denosumab. Transplantation 101:2139\u20132145","journal-title":"Transplantation"},{"issue":"10","key":"837_CR80","first-page":"CD005015","volume":"10","author":"SC Palmer","year":"2019","unstructured":"Palmer SC, Chung EY, McGregor DO et al (2019) Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev. 10(10):CD005015","journal-title":"Cochrane Database Syst Rev."},{"issue":"8","key":"837_CR81","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00198-016-3534-6","volume":"27","author":"R Lindsay","year":"2016","unstructured":"Lindsay R, Krege JH, Marin F, Jin L, Stepan JJ (2016) Teriparatide for osteoporosis importance of the full course. Osteoporos Int 27(8):2395\u20132410","journal-title":"Osteoporos Int"},{"key":"837_CR82","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","volume":"8","author":"D Cejka","year":"2008","unstructured":"Cejka D, Benesch T, Krestan C, Roschger P, Klaushofer K, Pietschmann P et al (2008) Effect of teriparatide on early bone loss after kidney transplantation. Am J Transplant 8:1864\u20131870","journal-title":"Am J Transplant"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00837-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-021-00837-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00837-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T05:59:05Z","timestamp":1619762345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-021-00837-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1007\/s00223-021-00837-0","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"assertion":[{"value":"4 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical standards"}},{"value":"Josep-Vicent Torregrosa has no conflict of interest, and Ana Carina Ferreira reports personal fees from Amgen and Vifor Pharma, outside the submitted work. David Cucchiari has no conflict of interest. An\u00edbal Ferreira reports personal fees, grants and participation in advisory boards from Abbvie, Astellas, Amgen, Baxter, Merck Sharp and Dhome, Mundipharma, Nephrocare-Fresenius Medical Care, Sanofi and Vifor Pharma, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}